BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34741082)

  • 21. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study.
    Liu F; Rong X; Guo H; Xu D; Liu C; Meng L; Yang X; Guo T; Kan X; Song Y
    BMC Gastroenterol; 2020 Feb; 20(1):30. PubMed ID: 32019495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome.
    He FL; Wang L; Zhao HW; Fan ZH; Zhao MF; Dai S; Yue ZD; Liu FQ
    World J Gastroenterol; 2015 Feb; 21(8):2413-8. PubMed ID: 25741149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological evaluation of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: Correlation with Drum Tower Severity Scoring.
    Li R; Li L; Cai Z; Chen J; Zhang H; Zhao S; Tu J; Sun C; Jin Y; Zhang M; Zhang F; Zhang W; Yin Q; Xu H; Han H; Li T; Zhuge Y; Xiao J
    Dig Liver Dis; 2024 Jul; 56(7):1220-1228. PubMed ID: 38151450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors of poor prognosis in patients with pyrrolidine alkaloids induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt : Transjugular intrahepatic portosystemic shunt in patients with sinusoidal obstruction syndrome, etiology matters.
    Magaz M; García-Pagán JC
    Hepatol Int; 2021 Jun; 15(3):568-570. PubMed ID: 33733320
    [No Abstract]   [Full Text] [Related]  

  • 25. Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors.
    Zhang F; Zhou Y; Yang X; Xiong AZ; Wang ZT; Yang L
    Acta Pharmacol Sin; 2019 Jun; 40(6):781-789. PubMed ID: 30367152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS).
    Zenz T; Rössle M; Bertz H; Siegerstetter V; Ochs A; Finke J
    Liver; 2001 Feb; 21(1):31-6. PubMed ID: 11169070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plateletcrit for predicting prognosis in patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloid.
    Tu H; Li M; Chen Z; Zhao J; Wang H; Qian J; Wei C; Yang Y; Zhu Y; Zuo L
    J Clin Lab Anal; 2022 Feb; 36(2):e24240. PubMed ID: 35034375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.
    Kan X; Ye J; Rong X; Lu Z; Li X; Wang Y; Yang L; Xu K; Song Y; Hou X
    Sci Rep; 2016 Nov; 6():37998. PubMed ID: 27897243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature.
    Campos-Varela I; Castells L; Dopazo C; Pérez-Lafuente M; Allende H; Len O; Llopart L; Vargas V; Charco R
    Liver Transpl; 2012 Feb; 18(2):201-5. PubMed ID: 21656652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.
    Azoulay D; Castaing D; Lemoine A; Samuel D; Majno P; Reynes M; Charpentier B; Bismuth H
    Clin Nephrol; 1998 Aug; 50(2):118-22. PubMed ID: 9725784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt.
    Senzolo M; Patch D; Cholongitas E; Triantos C; Marelli L; Stigliano R; Dhillon A; Burroughs A
    Transplantation; 2006 Jul; 82(1):132-5. PubMed ID: 16861953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
    Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.
    Lin G; Wang JY; Li N; Li M; Gao H; Ji Y; Zhang F; Wang H; Zhou Y; Ye Y; Xu HX; Zheng J
    J Hepatol; 2011 Apr; 54(4):666-73. PubMed ID: 21146894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study.
    Wang Y; Qiao D; Li Y; Xu F
    BMC Gastroenterol; 2018 Oct; 18(1):156. PubMed ID: 30367628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative Analysis of CT Images in Patients with Pyrrolizidine Alkaloid-Induced Sinusoidal Obstruction Syndrome.
    Wang C; Wu X; Xie W; Ren X; Zhang W; Xu J
    Sci Rep; 2019 Feb; 9(1):2179. PubMed ID: 30778132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports.
    Jiang M; Wang L; Du X; Hao M; Gao P
    J Int Med Res; 2020 Sep; 48(9):300060520961916. PubMed ID: 32993424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the efficacy of TIPS in 27 patients with hepatic sinus obstruction syndrome in the near and medium term].
    Wang L; Zhang Y; Wang XQ; Yue ZD; Fan ZH; Wu YF; Liu FQ; Dong J; Zhang K; Jiang L; Ding HG; Zhang YN
    Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):842-846. PubMed ID: 37723066
    [No Abstract]   [Full Text] [Related]  

  • 38. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation.
    Azoulay D; Castaing D; Lemoine A; Hargreaves GM; Bismuth H
    Bone Marrow Transplant; 2000 May; 25(9):987-92. PubMed ID: 10800068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Drum Tower Severity Scoring (DTSS) system for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
    Wang X; Zhang W; Zhang M; Zhang F; Xiao J; Yin Q; Han H; Li T; Lin G; Zhuge Y
    Hepatol Int; 2022 Jun; 16(3):669-679. PubMed ID: 35023026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gynura segetum induces hepatic sinusoidal obstruction syndrome in a child: A case report.
    Zheng Q; Zhang H
    Medicine (Baltimore); 2024 Mar; 103(11):e37341. PubMed ID: 38489699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.